Safety and Efficacy of Calcipotriene Plus Betamethasone Dipropionate Topical Suspension in the Treatment of Extensive Scalp Psoriasis in Adolescents Ages 12 to 17 Years

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-1470|32|1|28-35

ISSN： 0736-8046

Source： PEDIATRIC DERMATOLOGY, Vol.32, Iss.1, 2015-01, pp. : 28-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 6, 2015-06 ,pp. : 1193-1197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs

By Feldman Steven R.   Levi Eugenia   Pathak Prathamesh   Kakatkar Sonali   Balkrishnan Rajesh  

Journal of Medical Economics, Vol. 16, Iss. 12, 2013-12 ,pp. : 1405-1413

Informa Healthcare

Access to resources Recommend Favorite

The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis – an introduction

By Freeman Keith  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 197-203

Informa Healthcare

Access to resources Recommend Favorite

Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland

By Affleck Andrew G.   Bottomley Julia M.   Auland Merran   Jackson Peter   Ryttov Jacob  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 269-284

Informa Healthcare

Access to resources Recommend Favorite

Changes in interleukin‐17A, macrophage‐derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO‐ABLE study

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e33-e34

John Wiley & Sons Inc

Access to resources Recommend Favorite